✦ LIBER ✦

Second-line combination chemotherapy with docetaxel and nedaplatin for metastatic or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus cisplatin

✍ Scribed by Ryohei Kawabata; Hiroshi Imamura; Tomono Kishimoto; Shinji Kitamura; Yoshimi Hachino; Yukako Yasui; Misako Fujino; Chika Fujii; Hiroshi Furukawa

Publisher: Springer
Year: 2011
Tongue: English
Weight: 205 KB
Volume: 8
Category: Article
ISSN: 1612-9059
DOI: 10.1007/s10388-011-0277-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A retrospective study of second-line che

A retrospective study of second-line chemotherapy for unresectable or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus platinum

✍ Kentaro Yamazaki; Shuichi Hironaka; Narikazu Boku; Hirofumi Yasui; Akira Fukutom 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 248 KB

Preoperative chemotherapy with weekly do

Preoperative chemotherapy with weekly docetaxel plus low-dose cisplatin and 5-fluorouracil for stage II/III squamous cell carcinoma of the esophagus

✍ Takahiro Yoshida; Junichi Seike; Takanori Miyoshi; Hiromichi Yamai; Hirokazu Tak 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 280 KB

Dose escalation study of docetaxel and n

Dose escalation study of docetaxel and nedaplatin in patients with relapsed or refractory squamous cell carcinoma of the esophagus pretreated using cisplatin, 5-fluorouracil, and radiation

✍ Takashi Yoshioka; Masato Sakayori; Shunsuke Kato; Natsuko Chiba; Shukichi Miyaza 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 213 KB

Phase I trial of combined chemotherapy w

Phase I trial of combined chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for patients with locally advanced squamous cell carcinoma of the head and neck

✍ Mamoru Tsukuda; Yasukazu Mikami; Yuji Tanigaki; Hideaki Katori; Choichi Horiuchi 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 234 KB

A phase II trial of modified weekly irin

A phase II trial of modified weekly irinotecan and cisplatin for chemotherapy-naïve patients with metastatic or recurrent squamous cell carcinoma of the esophagus

✍ Dae Ho Lee; Heung Tae Kim; Ji-Youn Han; Sung Young Lee; Sung Jin Yoon; Hyae Youn 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 267 KB

Phase II trial of chemotherapy with 5-fl

Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type

✍ Abdelkrim Taamma; Abdelrahim Fandi; Nacer Azli; Pierre Wibault; Nadia Chouaki; A 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 2 views

## BACKGROUND. The aim of this study was to evaluate the toxicity and efficacy of the combination of 5-fluorouracil, bleomycin, epirubicin, and cisplatin (FBEC) in the treatment of patients with undifferentiated carcinoma of nasopharyngeal type (UCNT). The study included patients with metastatic or